ArticleInvestigational new drugs2015

A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.

Akiyoshi Kasuga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.